Related Experiment Videos
Ventricular arrhythmias in dilated cardiomyopathy
J Brachmann1, T Hilbel, E Grünig
1Department of Cardiology, University Hospital, Heidelberg, Germany. johannesbrachmann@krzmail.krz.uni-heidelberg.de
Pacing and Clinical Electrophysiology : PACE
|November 14, 1997
Summary
Sudden cardiac death remains a risk in dilated cardiomyopathy (DCM) despite improved treatments. Current methods for predicting risk are limited, but implantable cardioverter-defibrillators (ICDs) show promise for managing arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Research
Background:
- Dilated cardiomyopathy (DCM) prognosis has improved, yet sudden cardiac death (SCD) remains a significant concern.
- Spontaneous ventricular ectopy is common in DCM, but its prognostic value via Holter monitoring is debated.
- Noninvasive methods like late potentials and QT dispersion lack established prognostic utility for arrhythmogenic events in DCM.
Purpose of the Study:
- To review the current prognostic strategies for sudden cardiac death in dilated cardiomyopathy.
- To evaluate the effectiveness of various diagnostic and therapeutic interventions in predicting and preventing adverse outcomes in DCM patients.
- To explore emerging treatments for advanced DCM with high arrhythmia risk.
Main Methods:
- Review of existing literature on prognostic markers in dilated cardiomyopathy.
- Analysis of data regarding Holter monitoring, late potentials, QT dispersion, and programmed ventricular stimulation.
- Evaluation of preliminary data on implantable cardioverter-defibrillators (ICDs) and their role in risk stratification.
- Consideration of advanced therapies including heart transplantation and dynamic cardiomyoplasty.
Main Results:
- The prognostic significance of Holter monitoring for ventricular ectopy in DCM is controversial.
- Programmed ventricular stimulation has not consistently identified patients at risk for sudden death.
- Preliminary data suggest implantable cardioverter-defibrillators (ICDs) are promising for risk stratification in DCM.
- Progression of heart failure dictates prognosis in DCM patients with poor left ventricular function and ICDs.
Conclusions:
- Despite advances, sudden cardiac death remains a challenge in dilated cardiomyopathy.
- Current noninvasive and electrophysiological testing methods have limitations in predicting prognosis.
- Implantable cardioverter-defibrillators (ICDs) appear promising for managing arrhythmia risk in DCM.
- For end-stage heart failure, heart transplantation is definitive, while ICDs combined with dynamic cardiomyoplasty offer an alternative for high-risk, non-transplant candidates.